论文部分内容阅读
近年来,尿激酶(UK)静滴治疗急性心肌梗塞(AMI)已被广泛应用,但对UK的用量及其使用时间尚无一致意见。为此,我们观察了UK的不同剂量和不同滴注时间对疗效的影响,旨在探索国人的UK适宜剂量和使用时间。
In recent years, urokinase (UK) intravenous infusion of acute myocardial infarction (AMI) has been widely used, but the amount of UK and its use of time there is no consensus. To this end, we observed the effects of different dosages of UK and different instillation times on curative effects, aimed at exploring the appropriate dose and duration of use in the UK.